Paper17538231
Potassium channel opener pinacidil induces relaxation of the isolated human radial artery.
Stojnic N and 6 others. J Pharmacol Sci, 2007. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Potassium channel opener pinacidil induces relaxation of the isolated human radial artery. Papers, record 17538231. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17538231
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potassium channel opener pinacidil induces relaxation of the isolated human radial artery.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pinacidil | Major topic |
| Potassium Channels | Major topic |
| Radial Artery | Major topic |
| Vasodilator Agents | Major topic |
| Adenosine Triphosphate | |
| Dose-Response Relationship, Drug | |
| Endothelium, Vascular | |
| Enzyme Inhibitors | |
| Humans | |
| In Vitro Techniques | |
| Male | |
| Middle Aged | |
| Muscle, Smooth, Vascular | |
| Phenylephrine | |
| Potassium Channel Blockers | |
| Sodium-Calcium Exchanger | |
| Vasodilation |
Source PubMed
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42292796 | Potassium channel-targeted therapy in reducing vascular complications in diabetes mellitus: novel insights. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42292796 | PubMed |
| 39065708 | Effect of Type-2 Diabetes Mellitus on the Expression and Function of Smooth Muscle ATP-Sensitive Potassium Channels in Human Internal Mammary Artery Grafts. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39065708 | PubMed |
| 36326331 | Hydroxychloroquine induces endothelium-dependent and endothelium-independent relaxation of rat aorta. | Turk J Med Sci | 2022 | https://conductscience.org/library/papers/36326331 | PubMed |
| 22563439 | Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal disease. | PLoS One | 2012 | https://conductscience.org/library/papers/22563439 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SLC24A3 | 57419 | PubTator's text mining | https://conductscience.org/library/genes/57419 | NCBI Gene |
| SLC8A1 | 6546 | PubTator's text mining | https://conductscience.org/library/genes/6546 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17538231
GET https://conductscience.org/api/papers/v1/17538231/authors